Integrase interactor 1 (Ini1/hSNF5/BAF47/SMARCB1), the core subunit of the ATP-dependent chromatin-remodelling complex SWI/SNF, is a cellular interaction partner of the human immunodeficiency virus type 1 (HIV-1) integrase. Ini1/hSNF5 is recruited to HIV-1 pre-integration complexes before nuclear migration, suggesting a function in the integration process itself or a contribution to the preferential selection of transcriptionally active genes as integration sites of HIV-1. More recent evidence indicates, however, that, whilst Ini1/hSNF5 is dispensable for HIV-1 transduction per se, it may have an inhibitory effect on the early steps of HIV-1 replication but facilitates proviral transcription by enhancing Tat function. These partially contradictory observations prompted an investigation of the immediate and long-term effects of Ini1/hSNF5 depletion on the basal transcriptional potential of the virus promoter. Using small interfering RNAs, it was shown that Ini1/hSNF5-containing SWI/SNF complexes mediate transcriptional repression of the basal activity of the integrated HIV-1 long terminal repeat. Transient depletion of Ini1/hSNF5 during integration was accompanied by an early boost of HIV-1 replication. After the reappearance of Ini1/hSNF5, expression levels decreased and this was associated with increased levels of histone methylation at the virus promoter in the long term, indicative of epigenetic gene silencing. These results demonstrate the opposing effects of Ini1/hSNF5-containing SWI/SNF complexes on basal and Tat-dependent transcriptional activity of the HIV-1 promoter. It is proposed that Ini1/hSNF5 may be recruited to the HIV-1 pre-integration complex to initiate, immediately after integration, one of two mutually exclusive transcription programmes, namely post-integration latency or high-level, Tat-dependent gene expression.
BoeseA.,
SommerP.,
GaussinA.,
ReimannA.,
NehrbassU.2004; Ini1/hSNF5 is dispensable for retrovirus-induced cytoplasmic accumulation of PML and does not interfere with integration. FEBS Lett 578:291–296[CrossRef]
ChengS. W.,
DaviesK. P.,
YungE.,
BeltranR. J.,
YuJ.,
KalpanaG. V.1999; c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat Genet 22:102–105[CrossRef]
CiuffiA.,
LlanoM.,
PoeschlaE.,
HoffmannC.,
LeipzigJ.,
ShinnP.,
EckerJ. R.,
BushmanF.2005; A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 11:1287–1289[CrossRef]
CiuffiA.,
DiamondT. L.,
HwangY.,
MarshallH. M.,
BushmanF. D.2006; Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor. Hum Gene Ther 17:960–967[CrossRef]
GregerJ. G.,
KatzR. A.,
IshovA. M.,
MaulG. G.,
SkalkaA. M.2005; The cellular protein Daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription. J Virol 79:4610–4618[CrossRef]
HendersonA.,
HollowayA.,
ReevesR.,
TremethickD. J.2004; Recruitment of SWI/SNF to the human immunodeficiency virus type 1 promoter. Mol Cell Biol 24:389–397[CrossRef]
JordanA.,
DefechereuxP.,
VerdinE.2001; The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J 20:1726–1738[CrossRef]
KalpanaG. V.,
MarmonS.,
WangW.,
CrabtreeG. R.,
GoffS. P.1994; Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266:2002–2006[CrossRef]
KingstonR. E.,
BunkerC. A.,
ImbalzanoA. N.1996; Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev 10:905–920[CrossRef]
KwiatkowskiB.,
ChenS. Y.,
SchubachW. H.2004; CKII site in Epstein–Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation. J Virol 78:6067–6072[CrossRef]
LeeD.,
SohnH.,
KalpanaG. V.,
ChoeJ.1999; Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA. Nature 399:487–491[CrossRef]
LeeD.,
KimJ. W.,
SeoT.,
HwangS. G.,
ChoiE. J.,
ChoeJ.2002; SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem 277:22330–22337[CrossRef]
LusicM.,
MarcelloA.,
CeresetoA.,
GiaccaM.2003; Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J 22:6550–6561[CrossRef]
MahmoudiT.,
ParraM.,
VriesR. G.,
KauderS. E.,
VerrijzerC. P.,
OttM.,
VerdinE.2006; The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter. J Biol Chem 281:19960–19968[CrossRef]
MarcelloA.,
LusicM.,
PegoraroG.,
PellegriniV.,
BeltramF.,
GiaccaM.2004; Nuclear organization and the control of HIV-1 transcription. Gene 326:1–11[CrossRef]
PumferyA.,
DengL.,
MaddukuriA.,
de la FuenteC.,
LiH.,
WadeJ. D.,
LambertP.,
KumarA.,
KashanchiF.2003; Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Curr HIV Res 1:343–362[CrossRef]
Rozenblatt-RosenO.,
RozovskaiaT.,
BurakovD.,
SedkovY.,
TillibS.,
BlechmanJ.,
NakamuraT.,
CroceC. M.,
MazoA.,
CanaaniE.1998; The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc Natl Acad Sci U S A 95:4152–4157[CrossRef]
SchroderA. R.,
ShinnP.,
ChenH.,
BerryC.,
EckerJ. R.,
BushmanF.2002; HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110:521–529[CrossRef]
SommerP.,
VartanianJ. P.,
WachsmuthM.,
HenryM.,
GuetardD.,
Wain-HobsonS.2004; Anti-termination by SIV Tat requires flexibility of the nascent TAR structure. J Mol Biol 344:11–28[CrossRef]
TreandC.,
du CheneI.,
BresV.,
KiernanR.,
BenarousR.,
BenkiraneM.,
EmilianiS.2006; Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter. EMBO J 25:1690–1699[CrossRef]
TurelliP.,
DoucasV.,
CraigE.,
MangeatB.,
KlagesN.,
EvansR.,
KalpanaG.,
TronoD.2001; Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol Cell 7:1245–1254[CrossRef]
Van LintC.,
EmilianiS.,
OttM.,
VerdinE.1996; Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J 15:1112–1120
VerdinE.,
ParasP.,
Jr & Van LintC.1993; Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J 12:3249–3259
WuD. Y.,
KalpanaG. V.,
GoffS. P.,
SchubachW. H.1996; Epstein–Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF–SWI complex, hSNF5/Ini1. J Virol 70:6020–6028
WuD. Y.,
KrummA.,
SchubachW. H.2000; Promoter-specific targeting of human SWI–SNF complex by Epstein–Barr virus nuclear protein 2. J Virol 74:8893–8903[CrossRef]
ZennouV.,
PetitC.,
GuetardD.,
NehrbassU.,
MontagnierL.,
CharneauP.2000; HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101:173–185[CrossRef]